Thoratec Corporation  

(Public, NASDAQ:THOR)   Watch this stock  
Find more results for THOR
63.29
0.00 (0.00%)
Jul 31 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 63.23 - 63.43
52 week 22.50 - 63.51
Open 63.27
Vol / Avg. 1.04M/1.45M
Mkt cap 3.43B
P/E 82.48
Div/yield     -
EPS 0.77
Shares 54.20M
Beta 0.71
Inst. own 98%
Aug 4, 2015
Q2 2015 Thoratec Corp Earnings Call - 4:30PM EDT - Add to calendar
Aug 4, 2015
Q2 2015 Thoratec Corp Earnings Release - 4:00PM EDT - Add to calendar
Jul 22, 2015
Preliminary Q2 2015 Thoratec Corp Earnings Release
Jun 9, 2015
Thoratec Corp at Goldman Sachs Healthcare Conference
May 14, 2015
Thoratec Corp at Bank of America Merrill Lynch Health Care Conference
May 7, 2015
Q1 2015 Thoratec Corp Earnings Call - Webcast
May 7, 2015
Q1 2015 Thoratec Corp Earnings Release
May 5, 2015
Thoratec Corp Annual Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '15) 2015
Net profit margin 8.89% 10.55%
Operating margin 14.79% 14.64%
EBITD margin - 18.10%
Return on average assets 5.65% 6.48%
Return on average equity 6.77% 7.76%
Employees 954 -
CDP Score - -

Address

6035 Stoneridge Dr
PLEASANTON, CA 94588
United States - Map
+1-925-8478600 (Phone)
+1-925-8478571 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Thoratec Corporation develops, manufactures and markets medical devices used for mechanical circulatory support for the treatment of heart failure patients. The Company’s products include ventricular assist devices (VADs), such as HeartMate II Left Ventricular Assist System (HeartMate II), HeartMate III Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device (PVAD) and Thoratec Implantable Ventricular Assist Device (IVAD). For acute circulatory support, the Company’s product lines are CentriMag Acute Circulatory System (CentriMag) and for pediatric patients PediMag/PediVAS Acute Circulatory System (PediMag/PediVAS). HeartMate III, a centrifugal-flow, chronic, left ventricular assist system.

Officers and directors

Neil F. Dimick CPA Independent Chairman of the Board
Age: 65
Bio & Compensation  - Reuters
Taylor C. Harris Chief Financial Officer, Vice President
Age: 39
Bio & Compensation  - Reuters
Marta Antonucci President, International
Bio & Compensation  - Reuters
Niamh Louise Pellegrini President - North America
Age: 48
Bio & Compensation  - Reuters
David A. Lehman Senior Vice President, General Counsel, Secretary
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Vasant Padmanabhan Ph.D. Senior Vice President - Technical Operations
Age: 47
Bio & Compensation  - Reuters
D. Keith Grossman President, Chief Executive Officer, Director
Bio & Compensation  - Reuters
J. Daniel Cole Independent Director
Age: 68
Bio & Compensation  - Reuters
Steven H. Collis Independent Director
Age: 53
Bio & Compensation  - Reuters
William A. Hawkins III Independent Director
Age: 61
Bio & Compensation  - Reuters